Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers launch lung cancer screening trial

Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease.

9 May 2008

FDA approves Strattera for ADHD in children and adolescents

Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.

8 May 2008

Bird flu pandemic risk just as real and probably growing

Experts are warning that the risk of a human bird flu pandemic remains just as real and is in fact probably growing.

8 May 2008

Experts review influenza pandemic preparedness guidance

With the onging threat of a global influenza pandemic demanding continued vigilance, 120 influenza and planning experts from WHO Member States, research institutions and UN agencies around the globe are meeting in Geneva this week to review the current WHO pandemic preparedness guidance. Key scientific and situational developments make the review particularly important. WHO will release the revised guidance later this year.

7 May 2008

GenVec announces grant for respiratory syncytial virus vaccine program

GenVec, Inc. announced today that it has received an Advanced Technology Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases, of the National Institutes of Health, to support the Company's efforts to develop vaccines for the prevention of respiratory syncytial virus (RSV).

7 May 2008

Bird flu pandemic risk just as real and probably growing

Experts are warning that the risk of a human bird flu pandemic remains just as real and is in fact probably growing.

7 May 2008

Relief in sight for arthritis triggered by viral infections such as Ross River fever

Australian scientists believe they may have discovered the possibility of relief for those suffering with the debilitating arthritis triggered by viral infections such as Ross River fever.

6 May 2008

Computer keyboard five times filthier than the toilet seat!

According to scientists in Britain your computer keyboard could contain a virus which threatens more than just what is on the screen - they say it poses a considerable health risk which equates to those presented by a toilet seat.

6 May 2008

MRSA spreading say American Society of Registered Nurses

Today the American Society of Registered Nurses announced that cases of MRSA also known as Methicillin - Resistant Staphylococcus aureus often called "Staph" are on the rise.

5 May 2008

New weapon against respiratory syncytial virus

University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.

5 May 2008

Strange barriers to physical activity may exist at child-care centers

At a time when over half of US children (aged 3-6) are in child care centers, and growing concern over childhood obesity has led physicians to focus on whether children are getting enough physical activity, a new study of outdoor physical activity at child care centers, conducted by researchers at Cincinnati Children's Hospital Medical Center, has identified some surprising reasons why the kids may be staying inside.

5 May 2008

Anti-HIV NanoViricide drug candidate shows promise in animal trials

NanoViricides, Inc said that its anti-HIV drug candidates demonstrated significant therapeutic efficacy in the recently completed preliminary animal studies.

5 May 2008

Novavax opens new U.S. vaccine plant in Rockville, Maryland

Officials from Novavax, Inc., the State of Maryland and Montgomery County today celebrated the opening of Novavax's new state-of-the-art vaccine production facility at the company's headquarters in Rockville, Maryland.

1 May 2008

Young children hospitalized for flu associated with higher costs and higher risk illness

The high costs of hospitalizing young children for influenza creates a significant economic burden in the United States, underscoring the importance of preventive flu shots for children and the people with whom they have regular contact, according to research led by Cincinnati Children's Hospital Medical Center and presented May 4 at the Pediatric Academic Society annual meeting in Honolulu, Hawaii.

30 Apr 2008

ImmunoVaccine Technologies patents DepoVax vaccine platform

ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax concept.

30 Apr 2008

AstraZeneca submits sNDA for SYMBICORT in chronic obstructive pulmonary disease

AstraZeneca today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). SYMBICORT is currently approved for the long-term maintenance treatment of asthma in patients 12 years and older.

30 Apr 2008

Discovery of quick method for making human monoclonal antibodies against flu

Human monoclonal antibodies (mAbs) - highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing cell - against influenza can be rapidly produced in the lab, according to a new report from scientists supported by the National Institutes of Health (NIH).

30 Apr 2008